Inaktiver Wert

Andere Sprachen MiMedx Group Inc Nasdaq

Aktien

US6024961012

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

MiMedx Group Promotes Kim Moller to Chief Commercial Officer	26.06.
MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer	26.06.
MiMedx Group, Inc. Announces the Appointment of Kim Moller to Chief Commercial Officer	26.06.
4 Stocks to Watch in the Booming Regenerative Medicine Market	20.05.
MIMEDX to Participate in Upcoming Investor Conferences	15.05.
Earnings Flash (MDXG) MIMEDX GROUP Posts Q1 Revenue $84.7M, vs. Street Est of $79.4M	30.04.
Earnings Flash (MDXG) MIMEDX GROUP Posts Q1 EPS $0.07, vs. Street Est of $0.04	30.04.
MiMedx: Q1 Earnings Snapshot	30.04.
MiMedx Group, Inc. Reports Consolidated Impairment for the First Quarter Ended March 31, 2024	30.04.
MiMedx Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30.04.
MIMEDX Announces First Quarter 2024 Operating and Financial Results	30.04.
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30	16.04.
MIMEDX Provides Update on AXIOFILL Request for Designation from FDA	28.03.
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024	27.03.
MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products	27.03.
MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit	27.03.
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA	27.03.
MiMedx Group, Inc. Provides Update on AXIOFILL Request for Designation from FDA	27.03.
MiMedx Group to Buy Distribution Rights for TELA Bio's Wound Care Product	20.03.
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing	20.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen MiMedx Group Inc Nasdaq

Aktien

US6024961012

Andere Sprachen

Filter